These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

247 related items for PubMed ID: 34301165

  • 1. Effect of Periodized Resistance Training on Skeletal Muscle During Androgen Deprivation Therapy for Prostate Cancer: A Pilot Randomized Trial.
    Dawson JK, Dorff TB, Tuzon C, Rice JC, Schroeder ET, Lane CJ, Gross ME, Dieli-Conwright CM.
    Integr Cancer Ther; 2021; 20():15347354211035442. PubMed ID: 34301165
    [Abstract] [Full Text] [Related]

  • 2. Impact of resistance training on body composition and metabolic syndrome variables during androgen deprivation therapy for prostate cancer: a pilot randomized controlled trial.
    Dawson JK, Dorff TB, Todd Schroeder E, Lane CJ, Gross ME, Dieli-Conwright CM.
    BMC Cancer; 2018 Apr 03; 18(1):368. PubMed ID: 29614993
    [Abstract] [Full Text] [Related]

  • 3. A pilot randomised controlled trial of a periodised resistance training and protein supplementation intervention in prostate cancer survivors on androgen deprivation therapy.
    Kiwata JL, Dorff TB, Todd Schroeder E, Salem GJ, Lane CJ, Rice JC, Gross ME, Dieli-Conwright CM.
    BMJ Open; 2017 Jul 10; 7(7):e016910. PubMed ID: 28698349
    [Abstract] [Full Text] [Related]

  • 4. Moderators of resistance-based exercise programs' effect on sarcopenia-related measures in men with prostate cancer previously or currently undergoing androgen deprivation therapy: An individual patient data meta-analysis.
    Lopez P, Newton RU, Taaffe DR, Winters-Stone K, Galvão DA, Buffart LM.
    J Geriatr Oncol; 2023 Jun 10; 14(5):101535. PubMed ID: 37229882
    [Abstract] [Full Text] [Related]

  • 5. Resistance training reduces disability in prostate cancer survivors on androgen deprivation therapy: evidence from a randomized controlled trial.
    Winters-Stone KM, Dobek JC, Bennett JA, Dieckmann NF, Maddalozzo GF, Ryan CW, Beer TM.
    Arch Phys Med Rehabil; 2015 Jan 10; 96(1):7-14. PubMed ID: 25194450
    [Abstract] [Full Text] [Related]

  • 6. Time on androgen deprivation therapy and adaptations to exercise: secondary analysis from a 12-month randomized controlled trial in men with prostate cancer.
    Taaffe DR, Buffart LM, Newton RU, Spry N, Denham J, Joseph D, Lamb D, Chambers SK, Galvão DA.
    BJU Int; 2018 Feb 10; 121(2):194-202. PubMed ID: 28872752
    [Abstract] [Full Text] [Related]

  • 7. Comparing eccentric resistance exercise in prostate cancer survivors on and off hormone therapy: a pilot study.
    Hansen PA, Dechet CB, Porucznik CA, LaStayo PC.
    PM R; 2009 Nov 10; 1(11):1019-24. PubMed ID: 19942188
    [Abstract] [Full Text] [Related]

  • 8. Resistance Exercise Training, a Simple Intervention to Preserve Muscle Mass and Strength in Prostate Cancer Patients on Androgen Deprivation Therapy.
    Houben LHP, Beelen M, van Loon LJC, Beijer S.
    Int J Sport Nutr Exerc Metab; 2024 Mar 01; 34(2):122-134. PubMed ID: 38048764
    [Abstract] [Full Text] [Related]

  • 9. Resistance Exercise Training Increases Muscle Mass and Strength in Prostate Cancer Patients on Androgen Deprivation Therapy.
    Houben LHP, Overkamp M, VAN Kraaij P, Trommelen J, VAN Roermund JGH, DE Vries P, DE Laet K, VAN DER Meer S, Mikkelsen UR, Verdijk LB, VAN Loon LJC, Beijer S, Beelen M.
    Med Sci Sports Exerc; 2023 Apr 01; 55(4):614-624. PubMed ID: 36534950
    [Abstract] [Full Text] [Related]

  • 10. Radiotherapy before or during androgen-deprivation therapy does not blunt the exercise-induced body composition protective effects in prostate cancer patients: A secondary analysis of two randomized controlled trials.
    Newton RU, Mavropalias G, Fragala MS, Kraemer WJ, Häkkinen K, Taaffe DR, Spry N, Joseph D, Galvão DA.
    Exp Gerontol; 2021 Aug 01; 151():111427. PubMed ID: 34052346
    [Abstract] [Full Text] [Related]

  • 11. A randomized controlled trial on the effectiveness of strength training on clinical and muscle cellular outcomes in patients with prostate cancer during androgen deprivation therapy: rationale and design.
    Thorsen L, Nilsen TS, Raastad T, Courneya KS, Skovlund E, Fosså SD.
    BMC Cancer; 2012 Mar 29; 12():123. PubMed ID: 22458865
    [Abstract] [Full Text] [Related]

  • 12. Effects of strength training on body composition, physical functioning, and quality of life in prostate cancer patients during androgen deprivation therapy.
    Nilsen TS, Raastad T, Skovlund E, Courneya KS, Langberg CW, Lilleby W, Fosså SD, Thorsen L.
    Acta Oncol; 2015 Nov 29; 54(10):1805-13. PubMed ID: 25927504
    [Abstract] [Full Text] [Related]

  • 13. Effects of strength training on muscle cellular outcomes in prostate cancer patients on androgen deprivation therapy.
    Nilsen TS, Thorsen L, Fosså SD, Wiig M, Kirkegaard C, Skovlund E, Benestad HB, Raastad T.
    Scand J Med Sci Sports; 2016 Sep 29; 26(9):1026-35. PubMed ID: 26282343
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The effects of resistance exercise on body composition and physical function in prostate cancer patients undergoing androgen deprivation therapy: an update systematic review and meta-analysis.
    Tian S, Ding M, Sun H.
    Aging Male; 2022 Dec 29; 25(1):281-292. PubMed ID: 36382930
    [Abstract] [Full Text] [Related]

  • 16. Responsiveness to Resistance-Based Multimodal Exercise Among Men With Prostate Cancer Receiving Androgen Deprivation Therapy.
    Taaffe DR, Newton RU, Spry N, Joseph DJ, Galvão DA.
    J Natl Compr Canc Netw; 2019 Oct 01; 17(10):1211-1220. PubMed ID: 31590154
    [Abstract] [Full Text] [Related]

  • 17. Resistance training and reduction of treatment side effects in prostate cancer patients.
    Galvão DA, Nosaka K, Taaffe DR, Spry N, Kristjanson LJ, McGuigan MR, Suzuki K, Yamaya K, Newton RU.
    Med Sci Sports Exerc; 2006 Dec 01; 38(12):2045-52. PubMed ID: 17146309
    [Abstract] [Full Text] [Related]

  • 18. Creatine supplementation and resistance training to preserve muscle mass and attenuate cancer progression (CREATINE-52): a protocol for a double-blind randomized controlled trial.
    Coletta AM, Simon LH, Maslana K, Taylor S, Larson K, Hansen PA, Thomas VM, Ulrich CM, Kohli M, Chipman J, Swami U, Gupta S, Maughan BL, Agarwal N.
    BMC Cancer; 2024 Apr 18; 24(1):493. PubMed ID: 38637770
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Exercise Mode Specificity for Preserving Spine and Hip Bone Mineral Density in Prostate Cancer Patients.
    Newton RU, Galvão DA, Spry N, Joseph D, Chambers SK, Gardiner RA, Wall BA, Bolam KA, Taaffe DR.
    Med Sci Sports Exerc; 2019 Apr 18; 51(4):607-614. PubMed ID: 30395051
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.